FR2827288B1 - Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Info

Publication number
FR2827288B1
FR2827288B1 FR0109260A FR0109260A FR2827288B1 FR 2827288 B1 FR2827288 B1 FR 2827288B1 FR 0109260 A FR0109260 A FR 0109260A FR 0109260 A FR0109260 A FR 0109260A FR 2827288 B1 FR2827288 B1 FR 2827288B1
Authority
FR
France
Prior art keywords
pyrido
preparing
pharmaceutical compositions
compositions containing
pyrazine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0109260A
Other languages
English (en)
French (fr)
Other versions
FR2827288A1 (fr
Inventor
Solo Goldstein
Guillaume Poissonnet
Jean Gilles Parmentier
Pierre Lestage
Brian Lockhart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Priority to FR0109260A priority Critical patent/FR2827288B1/fr
Priority to MXPA02006699A priority patent/MXPA02006699A/es
Priority to JP2002201793A priority patent/JP3950018B2/ja
Priority to BR0202681-3A priority patent/BR0202681A/pt
Priority to ES02291745T priority patent/ES2210219T3/es
Priority to NO20023345A priority patent/NO322966B1/no
Priority to TR2003/02001T priority patent/TR200302001T4/xx
Priority to AT02291745T priority patent/ATE254124T1/de
Priority to SI200230005T priority patent/SI1275647T1/xx
Priority to NZ520120A priority patent/NZ520120A/en
Priority to DK02291745T priority patent/DK1275647T3/da
Priority to EP02291745A priority patent/EP1275647B1/fr
Priority to PT02291745T priority patent/PT1275647E/pt
Priority to DE60200089T priority patent/DE60200089T2/de
Priority to EA200200663A priority patent/EA005160B1/ru
Priority to ZA200205596A priority patent/ZA200205596B/xx
Priority to CA002394027A priority patent/CA2394027C/fr
Priority to US10/195,019 priority patent/US6992085B2/en
Priority to ARP020102607A priority patent/AR036166A1/es
Priority to KR10-2002-0040727A priority patent/KR100485020B1/ko
Priority to HU0202282A priority patent/HUP0202282A3/hu
Priority to CNB021241481A priority patent/CN1197863C/zh
Priority to AU2002300094A priority patent/AU2002300094B2/en
Priority to PL02355034A priority patent/PL355034A1/xx
Publication of FR2827288A1 publication Critical patent/FR2827288A1/fr
Priority to HK03102800.3A priority patent/HK1050682B/xx
Application granted granted Critical
Publication of FR2827288B1 publication Critical patent/FR2827288B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR0109260A 2001-07-12 2001-07-12 Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent Expired - Fee Related FR2827288B1 (fr)

Priority Applications (25)

Application Number Priority Date Filing Date Title
FR0109260A FR2827288B1 (fr) 2001-07-12 2001-07-12 Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MXPA02006699A MXPA02006699A (es) 2001-07-12 2002-07-05 Nuevos compuestos de octahidro-2h-pirod[1,2-a]pirazina, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
JP2002201793A JP3950018B2 (ja) 2001-07-12 2002-07-10 新規なオクタヒドロ−２Ｈ−ピリド〔１，２−ａ〕ピラジン化合物、それらの製造方法およびそれらを含む医薬組成物
DE60200089T DE60200089T2 (de) 2001-07-12 2002-07-11 Octahydro-2H-pyrido[1,2-a]pyrazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
NO20023345A NO322966B1 (no) 2001-07-12 2002-07-11 Nye oktahydro-2H-pyrido[1-2-a]pyrazinforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem
TR2003/02001T TR200302001T4 (tr) 2001-07-12 2002-07-11 ''Oktahidro-2H-pirido[1,2-a] pirazin türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler''
AT02291745T ATE254124T1 (de) 2001-07-12 2002-07-11 Octahydro-2h-pyrido(1,2-a)pyrazinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
SI200230005T SI1275647T1 (en) 2001-07-12 2002-07-11 Octahydro-2H-pyrido(1,2-a)pyrazine derivatives, process for their preparation and pharmaceutical compositions containing them
NZ520120A NZ520120A (en) 2001-07-12 2002-07-11 New octahydro-2H-pyrido[1,2-a]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them
DK02291745T DK1275647T3 (da) 2001-07-12 2002-07-11 Octahydro-1H-pyrido[1,2-a]pyrazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
EP02291745A EP1275647B1 (fr) 2001-07-12 2002-07-11 Dérivés d'octahydro-2H-pyrido[1,2-a]pyrazine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
PT02291745T PT1275647E (pt) 2001-07-12 2002-07-11 Derivados de octa-hidro-2h-pirido¬1,2-a|pirazina processo para a sua preparacao e as composicoes farmaceuticas que os contem
BR0202681-3A BR0202681A (pt) 2001-07-12 2002-07-11 Compostos de octaidro-2h-pirido[1,2a]pirazina, um processo para sua preparação e composições farmacêuticas contendo-as
EA200200663A EA005160B1 (ru) 2001-07-12 2002-07-11 НОВЫЕ СОЕДИНЕНИЯ ОКТАГИДРО-2H-ПИРИДО[1,2-α]ПИРАЗИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ, ИХ СОДЕРЖАЩИЕ
ES02291745T ES2210219T3 (es) 2001-07-12 2002-07-11 Derivados de octahidro-2h-pirido- (1,2-a) -pirazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
ZA200205596A ZA200205596B (en) 2001-07-12 2002-07-12 Octahydro-2H-Pyrido[1,2-A]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them.
US10/195,019 US6992085B2 (en) 2001-07-12 2002-07-12 Octahydro-2H-pyrido[1,2-a]pyrazine compounds
ARP020102607A AR036166A1 (es) 2001-07-12 2002-07-12 Compuestos de octahidro-2h-pirido[1,2-a]piracina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen
KR10-2002-0040727A KR100485020B1 (ko) 2001-07-12 2002-07-12 옥타하이드로-2Ｈ-피리도[1,2-ａ]피라진 화합물, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물
HU0202282A HUP0202282A3 (en) 2001-07-12 2002-07-12 Novel octahydro-2h-pyrido[1,2-a]pyrazine compounds, process for their preparation and pharmaceutical compositions containing them
CNB021241481A CN1197863C (zh) 2001-07-12 2002-07-12 新的八氢－2H－吡啶并[1,2－a]吡嗪化合物、它们的制备方法和含有它们的药物组合物
CA002394027A CA2394027C (fr) 2001-07-12 2002-07-12 Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PL02355034A PL355034A1 (en) 2001-07-12 2002-07-12 New compounds octahydro-2-h-pyride[1,2-a]pyrazines, method of their manufacture and containing them pharmaceutical compositions
AU2002300094A AU2002300094B2 (en) 2001-07-12 2002-07-12 New octahydro-2H-pyrido[1,2-alpha]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them
HK03102800.3A HK1050682B (en) 2001-07-12 2003-04-17 New octahydro-2h-pyrido[1,2-a]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0109260A FR2827288B1 (fr) 2001-07-12 2001-07-12 Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
FR2827288A1 FR2827288A1 (fr) 2003-01-17
FR2827288B1 true FR2827288B1 (fr) 2003-10-31

Family

ID=8865405

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0109260A Expired - Fee Related FR2827288B1 (fr) 2001-07-12 2001-07-12 Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Country Status (24)

Country Link
US (1) US6992085B2 (enExample)
EP (1) EP1275647B1 (enExample)
JP (1) JP3950018B2 (enExample)
KR (1) KR100485020B1 (enExample)
CN (1) CN1197863C (enExample)
AR (1) AR036166A1 (enExample)
AT (1) ATE254124T1 (enExample)
AU (1) AU2002300094B2 (enExample)
BR (1) BR0202681A (enExample)
CA (1) CA2394027C (enExample)
DE (1) DE60200089T2 (enExample)
DK (1) DK1275647T3 (enExample)
EA (1) EA005160B1 (enExample)
ES (1) ES2210219T3 (enExample)
FR (1) FR2827288B1 (enExample)
HU (1) HUP0202282A3 (enExample)
MX (1) MXPA02006699A (enExample)
NO (1) NO322966B1 (enExample)
NZ (1) NZ520120A (enExample)
PL (1) PL355034A1 (enExample)
PT (1) PT1275647E (enExample)
SI (1) SI1275647T1 (enExample)
TR (1) TR200302001T4 (enExample)
ZA (1) ZA200205596B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089410A1 (ja) * 2003-04-03 2004-10-21 Kyowa Hakko Kogyo Co., Ltd. 神経因性疼痛の予防及び／または治療剤
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1761267A1 (en) * 2004-06-22 2007-03-14 Pfizer Products Incorporated Diazabicyclic histamine-3 receptor antagonists
RU2442775C2 (ru) * 2005-07-04 2012-02-20 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
EP2386554A1 (en) * 2005-07-04 2011-11-16 High Point Pharmaceuticals, LLC Compounds active at the histamine H3 receptor
EP1998620B1 (en) * 2006-03-10 2011-01-12 Neurogen Corporation Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
KR100871691B1 (ko) 2006-10-16 2008-12-05 삼성전자주식회사 병렬 비트 테스트 방법 및 그 방법을 사용하는 반도체메모리 장치
JP7015092B2 (ja) 2016-07-28 2022-02-02 塩野義製薬株式会社 ドーパミンｄ３受容体拮抗作用を有する含窒素縮環化合物
US11578084B2 (en) 2018-01-26 2023-02-14 Shionogi & Co., Ltd. Condensed ring compounds having dopamine D3 receptor antagonistic effect

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
GB8518236D0 (en) * 1985-07-19 1985-08-29 Beecham Group Plc Compounds
AU5291793A (en) * 1992-09-24 1994-04-12 National Institutes Of Health Aralkyl diazabicycloalkane derivatives for cns disorders
US6231833B1 (en) * 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
ES2274795T3 (es) * 1999-07-19 2007-06-01 Merck Frosst Canada Ltd. Pirazinonas, composiciones que contienen tales compuestos.

Also Published As

Publication number Publication date
EP1275647A1 (fr) 2003-01-15
PT1275647E (pt) 2004-03-31
HUP0202282A2 (hu) 2003-03-28
EA200200663A1 (ru) 2003-02-27
CA2394027C (fr) 2008-01-08
KR20030007159A (ko) 2003-01-23
EA005160B1 (ru) 2004-12-30
CN1397557A (zh) 2003-02-19
NO20023345D0 (no) 2002-07-11
US6992085B2 (en) 2006-01-31
MXPA02006699A (es) 2005-08-16
JP2003064081A (ja) 2003-03-05
HK1050682A1 (en) 2003-07-04
HUP0202282A3 (en) 2003-11-28
DE60200089D1 (de) 2003-12-18
DE60200089T2 (de) 2004-09-09
ATE254124T1 (de) 2003-11-15
DK1275647T3 (da) 2004-03-15
US20030195216A1 (en) 2003-10-16
ES2210219T3 (es) 2004-07-01
ZA200205596B (en) 2003-03-27
HU0202282D0 (enExample) 2002-09-28
TR200302001T4 (tr) 2004-01-21
PL355034A1 (en) 2003-01-13
CA2394027A1 (fr) 2003-01-12
AR036166A1 (es) 2004-08-18
EP1275647B1 (fr) 2003-11-12
AU2002300094B2 (en) 2007-06-14
BR0202681A (pt) 2003-05-06
FR2827288A1 (fr) 2003-01-17
CN1197863C (zh) 2005-04-20
KR100485020B1 (ko) 2005-04-25
NZ520120A (en) 2004-03-26
NO20023345L (no) 2003-01-13
NO322966B1 (no) 2006-12-18
SI1275647T1 (en) 2004-02-29
JP3950018B2 (ja) 2007-07-25

Similar Documents

Publication Publication Date Title
FR2824825B1 (fr) Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2796644B1 (fr) Nouveaux derives de beta-carboline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2822826B1 (fr) Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA26740A1 (fr) Derives de 13-methyl-erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2846656B1 (fr) Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2804429B1 (fr) Nouveaux derives de 4-sulfonamides piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2827288B1 (fr) Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HUP0105407A3 (en) Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
MA26413A1 (fr) DERIVES D'OCTAHYDRO-PYRROLO [1,2-a] PYRAZINE 2,7-SUBSTITUES, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
FR2803848B1 (fr) Nouveaux derives de benzenesulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2805259B1 (fr) Nouveaux derives d'aminoacides n-mercaptoacyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2818277B1 (fr) Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2815346B1 (fr) Nouveaux composes aminotriazolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2821843B1 (fr) Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HUP0105406A3 (en) Imidazo[1,2-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
FR2825091B1 (fr) Nouveaux derives tricycliques de dihydro-quinnoleines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2822153B1 (fr) Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2853649B1 (fr) Nouveaux derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2831169B1 (fr) Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2827284B1 (fr) Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2812291B1 (fr) Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2833950B1 (fr) Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2827864B1 (fr) Nouveaux derives de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2823752B1 (fr) Nouveaux derives de pyrimidin-4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA27407A1 (fr) Nouveaux derives de 2,3-dihydro-4(1h)-pyridinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060331